T2DM and metabolic syndrome patients showed lower levels of Irisin than healthy controls. There was a negative correlation between Irisin levels and levels of sVCAM‐1, sICAM‐2, and MCP‐1 in children and adolescents. This evidence concerns the gene CCL2 and metabolic syndrome.